NRx Pharmaceuticals (NRXP)
Develops NMDA-pathway CNS therapies alongside a majority-owned interventional-psychiatry clinic network.
$3.17
After hours+0.01 (+0.38%)
At close$3.16(−4.88%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 67.33% | 11.64M shares | |
|---|---|---|---|
| 52 holders · as of Jun 30, 2026 | |||
| Insiders | 0.49% | 84.6K shares | |
| 1 holder · as of Dec 18, 2024 | |||
| Strategic holders | 0.38% | 65.6K shares | |
| 1 holder · as of May 26, 2021 | |||
| Other | 31.80% | 5.50M shares | |
| remainder | |||
17.29M company shares as of Sep 13, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (43.30M in the company's Sep 23, 2026 report, 17.29M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
52 holders · 11.64M shares · 19 new positions · 37 increased · 5 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| B Group, Inc. | 4.09M | 23.67% | +1.09M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.62M | 9.36% | +458.0K | Aug 13, 2026 |
| Ameriprise Financial Inc | 928.7K | 5.37% | +928.7Knew | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 893.9K | 5.17% | +893.9Knew | Aug 14, 2026 |
| Citadel Advisors LLC | 680.0K | 3.93% | +680.0Knew | Sep 2, 2026 |
| Advisorshares Investments LLC | 659.0K | 3.81% | +238.6K | Aug 11, 2026 |
| Commonwealth Equity Services, LLC | 454.4K | 2.63% | +57.0K | Jul 29, 2026 |
| UBS Group AG | 423.1K | 2.45% | +397.9K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| The B Group, Inc. | 12.62% | 3.00M | 13G | Aug 21, 2025 |
| Anson Funds Management LP | 9.30% | 1.60M | 13G | Aug 14, 2025 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.